Research Article
[Retracted] Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
Table 5
Adverse reactions in the two groups [n(%)].
| | Group | Gastrointestinal reaction | Skin eruptions | Myelosuppression | Hepatic injury | Total incidence rate |
| | Control group (n = 77) | 32(41.6) | 3(3.8) | 8(10.4) | 2(2.6) | 45(58.4) | | Observation group (n = 79) | 35(44.3) | 2(2.5) | 9(11.4) | 3(3.8) | 49(62.0) | | χ2 | 0.1199 | 0.2340 | 0.0404 | 0.1810 | 0.2091 | | P | 0.7291 | 0.6286 | 0.8407 | 0.6705 | 0.6475 |
|
|
Chi-square test between groups.
|
